Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 9;18(1):435.
doi: 10.1186/s12891-017-1790-z.

p21-/- mice exhibit enhanced bone regeneration after injury

Affiliations

p21-/- mice exhibit enhanced bone regeneration after injury

Priyatha Premnath et al. BMC Musculoskelet Disord. .

Abstract

Background: p21(WAF1/CIP1/SDI1), a cyclin dependent kinase inhibitor has been shown to influence cell proliferation, differentiation and apoptosis; but more recently, p21 has been implicated in tissue repair. Studies on p21(-/-) knockout mice have demonstrated results that vary from complete regeneration and healing of tissue to attenuated healing. There have however been no studies that have evaluated the role of p21 inhibition in bone healing and remodeling.

Methods: The current study employs a burr-hole fracture model to investigate bone regeneration subsequent to an injury in a p21-/- mouse model. p21-/- and C57BL/6 mice were subjected to a burr-hole fracture on their proximal tibia, and their bony parameters were measured over 4 weeks via in vivo μCT scanning.

Results: p21-/- mice present with enhanced healing from week 1 through week 4. Differences in bone formation and resorption potential between the two mouse models are assessed via quantitative and functional assays. While the μCT analysis indicates that p21-/- mice have enhanced bone healing capabilities, it appears that the differences observed may not be due to the function of osteoblasts or osteoclasts. Furthermore, no differences were observed in the differentiation of progenitor cells (mesenchymal or monocytic) into osteoblasts or osteoclasts respectively.

Conclusions: Therefore, it remains unknown how p21 is regulating enhanced fracture repair and further studies are required to determine which cell type(s) are responsible for this regenerative phenotype.

Keywords: Bone healing; Mice; Trabecular bone; p21; μCT.

PubMed Disclaimer

Conflict of interest statement

Ethics approval

All animal procedures are approved by the University of Calgary Animal Care Committee.

Consent for publication

Not applicable.

Competing interests

RK is a member of the Editorial Board of BMC Musculoskeletal Disorders. The other authors declare they have no other competing interest.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Panel of representative μCT images illustrating trabecular morphology at day 0, Week 1, 2 and 4, post burr-hole surgery of p21−/− (ad) mice and C57BL/6 (eh) mice. It is observed that at week 1, both C57BL/6 and p21−/− mice showed expected regeneration at the ROI. By week 2, the bone has returned to a pre-injury morphology and remains stable through week 4. The red arrows indicate the location of the burr-hole fracture. Each mouse group (n) = 12. Scale bars: 1 mm
Fig. 2
Fig. 2
Quantitative analysis of bone histomorphometry properties obtained via μCT scanning of ROI surrounding the burr-hole fractures at day 0, week 1, 2 and 4 for C57BL/6 and p21−/− mice. *p < 0.05. The error bars indicate standard deviations
Fig. 3
Fig. 3
Runx2 (a) and sp7 (b) gene expression in C57BL/6 and p21−/− bone marrow derived MSCs before and after osteogenic differentiation. Histological (alizarin red) staining of calcium deposits in differentiated MSCs from C57BL/6 (c) and p21−/− (d) mice respectively. Error bars indicate standard deviation
Fig. 4
Fig. 4
No difference was observed in the resorptive capacity of osteoclasts derived from C57BL/6 or p21−/− mice (A; n = 4). Representative flow cytometry plots of osteoblasts and osteoclasts staining of cells isolated from the bone marrow demonstrating no difference in the number of osteoblasts or osteoclasts between C57BL/6 or p21−/− mice (B; n = 4). Error bars indicate standard deviation

Similar articles

Cited by

References

    1. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289:1508–1514. doi: 10.1126/science.289.5484.1508. - DOI - PubMed
    1. Cornell CN. Internal fracture fixation in patients with osteoporosis. J Am Acad Orthop Surg. 2003;11:109–119. doi: 10.5435/00124635-200303000-00005. - DOI - PubMed
    1. Egermann M, Goldhahn J, Schneider E. Animal models for fracture treatment in osteoporosis. Osteoporos Int. 2005;16(Suppl 2):S129–S138. doi: 10.1007/s00198-005-1859-7. - DOI - PubMed
    1. Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: state of the art and future trends. Macromol Biosci. 2004;4:743–765. doi: 10.1002/mabi.200400026. - DOI - PubMed
    1. Kimelman Bleich N, Kallai I, Lieberman JR, Schwarz EM, Pelled G, Gazit D. Gene therapy approaches to regenerating bone. Adv Drug Deliv Rev. 2012;64:1320–1330. doi: 10.1016/j.addr.2012.03.007. - DOI - PMC - PubMed

Substances

Grants and funding